Aquestive Therapeutics, Inc. · NASDAQ:AQST
Davis Matthew W. sold 7,197 Aquestive Therapeutics, Inc. shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 16, 2026
On Nov 12, 2026, Davis Matthew W. (Chief Development Officer) sold 7,197 Aquestive Therapeutics, Inc. shares at US$3.55 for US$25,526 under a trading plan, leaving 87,500 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 7,197 shares
- Price
- US$3.55
- Value
- US$25,526
- Holding after
- 87,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock | Sale | 7,197 | US$3.55 | 87,500 | Direct |
Source
Download original · View original at SEC
Related
- Aquestive Therapeutics, Inc.
- Davis Matthew W.
- Aquestive Therapeutics, Inc. shareholders
- Form 4 · Davis Matthew W. · Nov 12, 2026
- Form 4 · Daly Richard J · Nov 12, 2026
- Form 4 · Cochran John · Oct 23, 2026
- Form 4 · Barber Daniel · Oct 16, 2026
- Schedule 13G · Bass Edward P · Oct 7, 2026
- Schedule 13G/A · Bratton Douglas K · Oct 7, 2026